{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:05:05Z","timestamp":1790521505137,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1111\/bjd.15896","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T04:56:44Z","timestamp":1503032204000},"page":"350-356","source":"Crossref","is-referenced-by-count":200,"title":["Colchicine: an ancient drug with novel applications"],"prefix":"10.1093","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8185-1821","authenticated-orcid":false,"given":"B.","family":"Dasgeb","sequence":"first","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology; Thomas Jefferson University; Philadelphia PA U.S.A."},{"name":"Section of Analytical and Functional Biophotonics; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; Bethesda MD U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kornreich","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology; Thomas Jefferson University; Philadelphia PA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"McGuinn","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology; Thomas Jefferson University; Philadelphia PA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Okon","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology; Thomas Jefferson University; Philadelphia PA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Brownell","sequence":"additional","affiliation":[{"name":"Division of Basic and Translational Biophysics; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; Bethesda MD U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Sackett","sequence":"additional","affiliation":[{"name":"Dermatology Branch; Center for Cancer Research; National Cancer Institute; National Institutes of Health; Bethesda MD U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"10.1111\/bjd.15896-BIB0001|bjd15896-cit-0001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1871523011312010004","article-title":"Colchicine: an old wine in a new bottle?","volume":"12","author":"Roubille","year":"2013","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"10.1111\/bjd.15896-BIB0002|bjd15896-cit-0002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am J Med"},{"key":"10.1111\/bjd.15896-BIB0003|bjd15896-cit-0003","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1078-0432.CCR-11-0999","article-title":"Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale","volume":"18","author":"Komlodi-Pasztor","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.15896-BIB0004|bjd15896-cit-0004","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin Ther"},{"key":"10.1111\/bjd.15896-BIB0005|bjd15896-cit-0005","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.15896-BIB0006|bjd15896-cit-0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00917514","article-title":"Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules","volume":"16","author":"Asako","year":"1992","journal-title":"Inflammation"},{"key":"10.1111\/bjd.15896-BIB0007|bjd15896-cit-0007","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine","volume":"153","author":"Chia","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bjd.15896-BIB0008|bjd15896-cit-0008","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","article-title":"Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action","volume":"163","author":"Marques-da-Silva","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bjd.15896-BIB0009|bjd15896-cit-0009","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"10.1111\/bjd.15896-BIB0010|bjd15896-cit-0010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.15896-BIB0011|bjd15896-cit-0011","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/bjd.15896-BIB0012|bjd15896-cit-0012","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.clinthera.2011.01.008","article-title":"Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials","volume":"32","author":"Wortmann","year":"2010","journal-title":"Clin Ther"},{"key":"10.1111\/bjd.15896-BIB0013|bjd15896-cit-0013","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.2010.139360","article-title":"EULAR recommendations for calcium pyrophosphate deposition. Part II: management","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.15896-BIB0014|bjd15896-cit-0014","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial Mediterranean fever. A double-blind trial","volume":"291","author":"Dinarello","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.15896-BIB0015|bjd15896-cit-0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0049-0172(91)90019-V","article-title":"Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years","volume":"20","author":"Ben-Chetrit","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/bjd.15896-BIB0016|bjd15896-cit-0016","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0049-0172(05)80042-3","article-title":"Colchicine in the treatment of AA and AL amyloidosis","volume":"23","author":"Livneh","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/bjd.15896-BIB0017|bjd15896-cit-0017","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.15896-BIB0018|bjd15896-cit-0018","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.15896-BIB0019|bjd15896-cit-0019","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejim.2010.09.010","article-title":"Colchicine in clinical medicine. A guide for internists","volume":"21","author":"Cocco","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1111\/bjd.15896-BIB0020|bjd15896-cit-0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(75)80031-6","article-title":"Leucocyte movement and colchicine treatment in Beh\u00e7et's disease","volume":"2","author":"Matsumura","year":"1975","journal-title":"Lancet"},{"key":"10.1111\/bjd.15896-BIB0021|bjd15896-cit-0021","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.15896-BIB0022|bjd15896-cit-0022","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Beh\u00e7et's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1111\/bjd.15896-BIB0023|bjd15896-cit-0023","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2340\/00015555-1065","article-title":"Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases","volume":"91","author":"Kim","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.15896-BIB0024|bjd15896-cit-0024","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1346-8138.13395","article-title":"Oral colchicine monotherapy for epidermolysis bullosa acquisita: mechanism of action and efficacy","volume":"43","author":"Adachi","year":"2016","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.15896-BIB0025|bjd15896-cit-0025","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archderm.1995.01690240061009","article-title":"Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial","volume":"131","author":"Sais","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15896-BIB0026|bjd15896-cit-0026","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/ijd.13232","article-title":"Sweet's syndrome: a retrospective study of 90 cases from a tertiary care center","volume":"55","author":"Amouri","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.15896-BIB0027|bjd15896-cit-0027","first-page":"1423","article-title":"Treatment of chronic urticaria with colchicine","volume":"10","author":"Pho","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.15896-BIB0028|bjd15896-cit-0028","first-page":"1365","article-title":"[Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases]","volume":"129","author":"Fontes","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.15896-BIB0029|bjd15896-cit-0029","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.25011\/cim.v33i3.13725","article-title":"Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: a double-blind randomized clinical trial","volume":"33","author":"Pakfetrat","year":"2010","journal-title":"Clin Invest Med"},{"key":"10.1111\/bjd.15896-BIB0030|bjd15896-cit-0030","doi-asserted-by":"crossref","first-page":"5918393","DOI":"10.1155\/2016\/5918393","article-title":"Topical colchicine gel versus diclofenac sodium gel for the treatment of actinic keratoses: a randomized, double-blind study","volume":"2016","author":"Faghihi","year":"2016","journal-title":"Adv Med"},{"key":"10.1111\/bjd.15896-BIB0031|bjd15896-cit-0031","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09546630152696314","article-title":"Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses","volume":"12","author":"Akar","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.15896-BIB0032|bjd15896-cit-0032","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000018407","article-title":"Topical colchicine therapy for actinic keratoses","volume":"200","author":"Grima\u00eetre","year":"2000","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15896-BIB0033|bjd15896-cit-0033","doi-asserted-by":"crossref","first-page":"e1570","DOI":"10.1097\/MD.0000000000001570","article-title":"Colchicine significantly reduces incident cancer in gout male patients: a 12-year cohort study","volume":"94","author":"Kuo","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/bjd.15896-BIB0034|bjd15896-cit-0034","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2161-0444.1000341","article-title":"Colchicine-based hybrid anticancer drugs to combat tumor heterogeneity","volume":"6","author":"Punganuru","year":"2016","journal-title":"Med Chem (Los Angeles)"},{"key":"10.1111\/bjd.15896-BIB0035|bjd15896-cit-0035","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1111\/bjd.15896-BIB0036|bjd15896-cit-0036","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims","volume":"75","author":"Solomon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.15896-BIB0037|bjd15896-cit-0037","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1136\/annrheumdis-2016-209316","article-title":"Response to: \u2018Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomized trial?\u2019 by Giannopoulos and Deftereos","volume":"75","author":"Solomon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.15896-BIB0038|bjd15896-cit-0038","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/bjd.15896-BIB0039|bjd15896-cit-0039","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1111\/bjd.15896-BIB0040|bjd15896-cit-0040","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/bjd.15896-BIB0041|bjd15896-cit-0041","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0190-9622(96)90013-4","article-title":"Colchicine for epidermolysis bullosa acquisita","volume":"34","author":"Cunningham","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15896-BIB0042|bjd15896-cit-0042","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/ced.12863","article-title":"Generalized annular granuloma associated with crowned dens syndrome, which resolved with colchicine treatment","volume":"41","author":"Cozzani","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.15896-BIB0043|bjd15896-cit-0043","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00431-015-2594-5","article-title":"Efficacy of colchicine in a child with relapsing bullous Henoch-Sch\u00f6nlein purpura","volume":"175","author":"Allali","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1111\/bjd.15896-BIB0044|bjd15896-cit-0044","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa","volume":"223","author":"Zee","year":"2011","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15896-BIB0045|bjd15896-cit-0045","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archdermatol.2012.2221","article-title":"Successful treatment of recurrent idiopathic plantar eccrine hidradenitis with colchicine","volume":"148","author":"Scheer","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15896-BIB0046|bjd15896-cit-0046","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(99)70533-5","article-title":"Effect of colchicine in the subcorneal pustular dermatosis type of IgA pemphigus","volume":"40","author":"Hodak","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15896-BIB0047|bjd15896-cit-0047","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-4362.2002.01321.x","article-title":"Localized linear IgA disease responding to colchicine","volume":"41","author":"Benbenisty","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.15896-BIB0048|bjd15896-cit-0048","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamadermatol.2013.2705","article-title":"Neutrophilic urticaria with systemic inflammation: a case series","volume":"149","author":"Belani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.15896-BIB0049|bjd15896-cit-0049","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/ajd.12494","article-title":"Treatment of nodular vasculitis with colchicine","volume":"58","author":"Wee","year":"2016","journal-title":"Australas J Dermatol"},{"key":"10.1111\/bjd.15896-BIB0050|bjd15896-cit-0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-4362.2002.01434.x","article-title":"Purpura annularis telangiectoides with vasculitic ulcers treated with colchicine","volume":"41","author":"Pandhi","year":"2002","journal-title":"Int J Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.15896-BIB0051|bjd15896-cit-0051","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-4632.2008.03949.x","article-title":"Penile pyoderma gangrenosum: successful treatment with colchicine","volume":"47","author":"Parren","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.15896-BIB0052|bjd15896-cit-0052","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000079897","article-title":"Treatment of pyoderma gangrenosum with low-dose colchicine","volume":"209","author":"Kontochristopoulos","year":"2004","journal-title":"Dermatology"},{"key":"10.1111\/bjd.15896-BIB0053|bjd15896-cit-0053","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0190-9622(84)80102-4","article-title":"Colchicine for treatment of relapsing polychondritis","volume":"10","author":"Askari","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15896-BIB0054|bjd15896-cit-0054","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1067\/mjd.2002.105477","article-title":"Colchicine and indomethacin for the treatment of relapsing polychondritis","volume":"46","author":"Mark","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.15896-BIB0055|bjd15896-cit-0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0781.2010.00526.x","article-title":"Scleredema treated with broad-band ultraviolet A phototherapy plus colchicine","volume":"26","author":"Y\u00fcksek","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/bjd.15896-BIB0056|bjd15896-cit-0056","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000345712","article-title":"Successful treatment of scleredema diabeticorum by combining local PUVA and colchicine: a case report","volume":"4","author":"Kokpol","year":"2012","journal-title":"Case Rep Dermatol"},{"key":"10.1111\/bjd.15896-BIB0057|bjd15896-cit-0057","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MD.0000000000000013","article-title":"Urticarial vasculitis in northern Spain: clinical study of 21 cases","volume":"93","author":"Loricera","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/bjd.15896-BIB0058|bjd15896-cit-0058","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/jid.2014.17","article-title":"Role of CRD-BP in the growth of human basal cell carcinoma cells","volume":"134","author":"Noubissi","year":"2014","journal-title":"J Invest Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15896","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15896\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:29:15Z","timestamp":1676366955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/2\/350\/6732128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15896","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}